Notably, diabetic patients should be particularly aware of the heightened anxiety risk associated with MPO dysregulation, and anti-inflammatory approaches could be considered as adjunctive interventions to facilitate personalized treatment strategies. This evidence concerns the gene MPO and Anxiety.